Condition
Infant, Preterm
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07237139RecruitingPrimary
Pulmonary Volume Changes During Synchonized Noninvasive Positive Pressure Ventilation
NCT02482012Completed
Minor Increase Over Minimal Risk Research in NICU
NCT01477892Phase 1CompletedPrimary
Evaluation of Safety and Efficacy of Remifentanil in Pediatric Population
NCT01389882Phase 2CompletedPrimary
Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants
Showing all 4 trials